Work

GLS Inhibitor CB-839 Modulates Cellular Metabolism in AML and Potently Suppresses AML Cell Growth when Combined with 5-Azacitidine

Year: 2017

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/j.clml.2017.07.070

Authors: Tianyu Cai, Philip Lorenzi, Dinesh Rakheja, Michael Pontikos, Alessia Lodi, Lina Han, Qi Zhang, Helen Ma, Mohamed Rahmani, Tushar Bhagat, Thomas Horvath, Courtney DiNardo, Steven Grant, Stefano Tiziani, Amit Verma, Marina Konopleva

Institutions: The University of Texas MD Anderson Cancer Center, The University of Texas Southwestern Medical Center, The University of Texas at Austin, Virginia Commonwealth University, VCU Massey Comprehensive Cancer Center, Albert Einstein College of Medicine

Language: English

Topic: Cancer, Hypoxia, and Metabolism

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2751826290

FWCI: 0.247

Cites:

Cited by: 7

Related to: 10